drugset / Trial / NCT02341521

Evaluation of Metabolic Profile of OC000459

NCT02341521 ↗

NaSingle-groupOpen-label

Summary

An open label study in 9 male and 9 female healthy subjects to determine the pharmacokinetics of parent compound and metabolite after eight days of dosing.

Timeline

Start
2015-03
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject TIMAPIPRANT Small molecule 50 mg Oral

Indications